KU Leuven
Leuven, 3000, Belgium
NCT Number: NCT02737254
The purpose of this study is to investigate the effects of oxytocin and a cognitive bias modification (CBM) procedure on children's trust in their mother.
Looking for future studies?
Notify Me8 year–13 year
All sexes
Interventional
Phase 4
Leuven, 3000, Belgium
Previous research has shown that children can be trained to interpret ambiguous interactions with mother in a more secure way by use of a CBM procedure. A secure attachment-related processing bias can causally increase children's trust in mother's availability. The present study tests whether intranasal administration of oxytocin can increase the effect of a secure cognitive bias training. Oxytocin is a neuropeptide that is involved in human attachment and bonding. Intranasal administration of oxytocin can increase trust among people. After oxytocin or placebo administration, children are either trained to interpret ambiguous interactions with mother in a secure way or receive a neutral training unrelated to interpretation of maternal behavior. Pre- and post-intervention children's trust in mother, support seeking behavior and interpretation of maternal behavior is assessed. Moreover, possible oxytocin side-effects will be monitored.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
40 IU/ML nasal spray. One administration: children <40kg administer 12IU, children >40kg administer 24IU.
NaCl 0,9 % nasal spray.
Children are trained to interpret ambiguous maternal behavior in a secure way.
Children receive a training unrelated to the interpretation of maternal behavior.
Time frame: Immediately before and immediately after intervention
Trust in mother as measured by People in My Life Trust subscale.
Time frame: Immediately before and immediately after intervention
Observation of the quality of the approach of child towards mother during a puzzle task.
Time frame: Immediately before and immediately after intervention
After reading scenarios describing ambiguous maternal behavior, children will be presented with sentences describing secure interpretations of this behavior and are asked to rate on a 4-point Likert scale to what extent this did or did not happen in the scenario. Thereby, children's spontaneous secure interpretation of ambiguous maternal behavior can be assessed.
Time frame: Immediately before and immediately after intervention
After reading scenarios describing ambiguous maternal behavior, children will be presented with sentences describing insecure interpretations of this behavior and are asked to rate on a 4-point Likert scale to what extent this did or did not happen in the scenario, assessing children's spontaneous insecure interpretation of ambiguous maternal behavior.
Time frame: Throughout the CBM training, from around 60 minutes until 110 minutes after the start of the procedure
Reaction times to scenarios describing secure maternal behavior.
Time frame: Throughout the CBM training, from around 60 minutes until 110 minutes after the start of the procedure
Reaction times to scenarios describing insecure maternal behavior.
Time frame: Immediately after intervention and 24 hours after intervention
Questionnaire on possible oxytocin side-effects.
Time frame: Immediately before nasal spray, immediately before CBM training and immediately after CBM training
Children rate on two visual analogous scales how happy and how sad they feel.
Universitaire Ziekenhuizen KU Leuven
Other
The Effect of Oxytocin on the Training of Attachment-related Interpretation Bias in Middle Childhood
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06650462
Behavior, COVID-19
Norfolk, Virginia, United States
View Trial DetailsNCT07166770
Behavior, COVID-19
Norfolk, Virginia, United States
View Trial DetailsNCT04588883
ART, Acquired Immunodeficiency Syndrome
Maua, Meru County, Kenya
View Trial DetailsNCT06697171
Conflict of Interest, Credibility
Oshawa, Ontario, Canada
View Trial Details